Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Labor market affiliation of patients with myeloproliferative neoplasms: a population-based matched cohort study.
Svingel LS, Christensen SF, Kjærsgaard A, Stenling A, Paulsson B, Andersen CL, Christiansen CF, Stentoft J, Starklint J, Severinsen MT, Borg Clausen M, Hagemann Hilsøe M, Hasselbalch HC, Frederiksen H, Bak M, Mikkelsen EM. Svingel LS, et al. Among authors: starklint j. Acta Oncol. 2023 Oct;62(10):1286-1294. doi: 10.1080/0284186X.2023.2251670. Epub 2023 Sep 1. Acta Oncol. 2023. PMID: 37656802
Mortality risk associated with weekend and holiday hospitalizations amongst patients with hematological malignancies and febrile neutropenia.
Hansen DL, Bogh SB, Rewes A, Brabrand M, Christensen LM, Asdahl P, Hilsøe MH, Starklint J, Overgaard U, Gudbrandsdottir S, Frederiksen M, Thorsgaard M, Vestergaard H, Frederiksen H. Hansen DL, et al. Among authors: starklint j. Eur J Haematol. 2024 Oct;113(4):558-560. doi: 10.1111/ejh.14286. Epub 2024 Aug 8. Eur J Haematol. 2024. PMID: 39117448 No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 39112197
Use of statins and risk of myeloproliferative neoplasms: a Danish nationwide case-control study.
Tuyet Kristensen D, Kisbye Øvlisen A, Hjort Kyneb Jakobsen L, Tang Severinsen M, Hannig LH, Starklint J, Hagemann Hilsøe M, Pommer Vallentin A, Brabrand M, Hasselbalch HC, El-Galaly TC, Stidsholt Roug A. Tuyet Kristensen D, et al. Among authors: starklint j. Blood Adv. 2023 Jul 25;7(14):3450-3457. doi: 10.1182/bloodadvances.2023009784. Blood Adv. 2023. PMID: 36877642 Free PMC article.
Healthcare resource utilization in patients with myeloproliferative neoplasms: A Danish nationwide matched cohort study.
Christensen SF, Svingel LS, Kjaersgaard A, Stenling A, Darvalics B, Paulsson B, Andersen CL, Christiansen CF, Stentoft J, Starklint J, Severinsen MT, Clausen MB, Hilsøe MH, Hasselbalch HC, Frederiksen H, Mikkelsen EM, Bak M. Christensen SF, et al. Among authors: starklint j. Eur J Haematol. 2022 Nov;109(5):526-541. doi: 10.1111/ejh.13841. Epub 2022 Aug 26. Eur J Haematol. 2022. PMID: 35900040 Free PMC article.
[Elevated blood cell counts and vascular disease with the myeloproliferative neoplasms as model diseases].
Hasselbalch HC, Knudsen TA, Sørensen AL, Christensen SF, Larsen MK, Bak M, El Fassi D, Cordua S, Brabrand M, Thomsen G, Stentoft J, Starklint J, Ellervik C, Wienecke T, Bruun NE, Eickhardt-Dalbøge CE, Kjær L, Skov V. Hasselbalch HC, et al. Among authors: starklint j. Ugeskr Laeger. 2021 Oct 18;183(42):V03210282. Ugeskr Laeger. 2021. PMID: 34709157 Free article. Review. Danish.
Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses.
Knudsen TA, Skov V, Stevenson K, Werner L, Duke W, Laurore C, Gibson CJ, Nag A, Thorner AR, Wollison B, Hansen DL, Ellervik C, El Fassi D, de Stricker K, Ocias LF, Brabrand M, Bjerrum OW, Overgaard UM, Frederiksen M, Kristensen TK, Kruse TA, Thomassen M, Mourits-Andersen T, Severinsen MT, Stentoft J, Starklint J, Neuberg DS, Kjaer L, Larsen TS, Hasselbalch HC, Lindsley RC, Mullally A. Knudsen TA, et al. Among authors: starklint j. Blood Adv. 2022 Apr 12;6(7):2107-2119. doi: 10.1182/bloodadvances.2021004856. Blood Adv. 2022. PMID: 34507355 Free PMC article. Clinical Trial.
28 results